Antiglaucoma drugs: The role of preservative-free formulations. - Wikidata - wikimedia - TriplyDB

Antiglaucoma drugs: The role of preservative-free formulations.

Antiglaucoma drugs: The role of preservative-free formulations.

http://www.wikidata.org/entity/Q37060734

about

A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits.Allergic reactions to atropine eye drops for retardation of progressive myopia in children

P2860

Q49178878-11BF91DE-E5C4-4999-B8A2-B39BBF3561EF Q58792618-61EE4EF6-B9C3-43A3-A13C-E2CE2F1AF14D

P2860

Antiglaucoma drugs: The role of preservative-free formulations.

http://www.wikidata.org/entity/Q37060734

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 August 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiglaucoma drugs: The role of preservative-free formulations.

@en

Antiglaucoma drugs: The role of preservative-free formulations.

@nl

type

label

Antiglaucoma drugs: The role of preservative-free formulations.

@en

Antiglaucoma drugs: The role of preservative-free formulations.

@nl

prefLabel

Antiglaucoma drugs: The role of preservative-free formulations.

@en

Antiglaucoma drugs: The role of preservative-free formulations.

@nl

P1433

Q37060734-663A097C-B38A-4695-AA65-2A8721FA8562

P1476

Q37060734-1C0E358C-4A6C-46F9-8F70-E096BAA3B238

P2093

Q37060734-1A078506-3E42-47C8-853E-0ECC349854BA

Q37060734-47F63507-A5AA-4186-BA98-71B756FA7210

Q37060734-6AA7084F-D127-429B-92D6-CFB2DBBC5B3D

Q37060734-7975254B-0F6C-4C1A-AF85-75399B91F457

P2860

Q37060734-04A7A1FF-F9D6-4B09-BF98-C752085F07A7

Q37060734-08462B58-6DC0-42D6-A7D8-492FFA822DDF

Q37060734-0F7E53FD-A107-4B18-80B2-1509C2549928

Q37060734-1141191A-A3BA-4849-BFFA-79976C3DD4C5

Q37060734-1AB3D9C4-09C7-4FFA-8C5F-F4E444B617B0

Q37060734-20010E4E-DC9F-4119-9DC4-9D780D983A75

Q37060734-2C9CFCD3-8F59-41AE-A3E6-F2E45156A394

Q37060734-2CF9BD37-03F9-4B3B-87B3-60CCB8530226

Q37060734-30809185-2555-4E43-8303-CA5AF458B9E6

Q37060734-4BAD771C-F80D-484D-92E5-9CC42F19282B

P304

Q37060734-91297D00-553B-4EB8-89CE-0CD5C9B1DD2D

P31

Q37060734-B969935A-37C2-49E8-993E-E579B82551EF

P356

Q37060734-226E1A46-7D1A-4C3C-93B4-746CABB64527

P433

Q37060734-602A3945-A641-44A1-980B-D44954745DE8

P478

Q37060734-4C8BEB28-C8DF-4FF3-A2EF-A8E38DA844F6

P577

Q37060734-2814FAB3-BA97-47C7-AC01-B0AB4142270D

P5875

Q37060734-A437A4C0-7BB3-44A3-9256-E6588B0EFCF6

P698

Q37060734-43ADC944-886F-46BC-A3CF-372C84511EFC

P932

Q37060734-90BE5826-5AE0-40CC-BEA6-CDE9251F823B

P356

J.SJOPT.2011.08.004

P1433

Saudi journal of ophthalmology

P1476

Antiglaucoma drugs: The role of preservative-free formulations.

@en

P2093

Alessandro Bagnis

http://www.w3.org/2001/XMLSchema#string

Carlo E Traverso

http://www.w3.org/2001/XMLSchema#string

Marina Papadia

http://www.w3.org/2001/XMLSchema#string

Riccardo Scotto

http://www.w3.org/2001/XMLSchema#string

P2860

Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells.

Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells.

Side effects of antiglaucomatous drugs on the ocular surface.

Considerations in glaucoma therapy: fixed combinations versus their component medications.

Preservatives in eyedrops: the good, the bad and the ugly.

Microbial contamination of eye drops.

Dry eye disease: the scale of the problem.

Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost.

Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.

Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study

P304

389-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SJOPT.2011.08.004

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255987671

http://www.w3.org/2001/XMLSchema#string

P698

23960953

http://www.w3.org/2001/XMLSchema#string

P932

3729930

http://www.w3.org/2001/XMLSchema#string